Published in J Neurosci on April 18, 2012
Iron and neurodegeneration in the multiple sclerosis brain. Ann Neurol (2013) 1.43
The benefits and detriments of macrophages/microglia in models of multiple sclerosis. Clin Dev Immunol (2013) 1.14
Priming the Inflammatory Pump of the CNS after Traumatic Brain Injury. Trends Neurosci (2015) 0.91
The effect of glia-glia interactions on oligodendrocyte precursor cell biology during development and in demyelinating diseases. Front Cell Neurosci (2013) 0.85
Phosphodiesterase-5 Inhibitors: Action on the Signaling Pathways of Neuroinflammation, Neurodegeneration, and Cognition. Mediators Inflamm (2015) 0.82
Comparison of histological techniques to visualize iron in paraffin-embedded brain tissue of patients with Alzheimer's disease. J Histochem Cytochem (2013) 0.82
Regenerative Capacity of Macrophages for Remyelination. Front Cell Dev Biol (2016) 0.80
Transferrin receptor and ferritin-H are developmentally regulated in oligodendrocyte lineage cells. Neural Regen Res (2013) 0.80
Reactive astrocytes undergo M1 microglia/macrohpages-induced necroptosis in spinal cord injury. Mol Neurodegener (2016) 0.79
Impaired myelination and reduced brain ferric iron in the mouse model of mucolipidosis IV. Dis Model Mech (2015) 0.79
Changes in NG2 cells and oligodendrocytes in a new model of intraspinal hemorrhage. Exp Neurol (2014) 0.79
Distribution and phenotype of TrkB oligodendrocyte lineage cells in the adult rat spinal cord. Brain Res (2014) 0.78
Persistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions. J Clin Invest (2016) 0.77
Rodent Models and Behavioral Outcomes of Cervical Spinal Cord Injury. J Spine (2013) 0.76
Cell transplantation therapy for spinal cord injury. Nat Neurosci (2017) 0.75
Accelerated neuronal differentiation toward motor neuron lineage from human embryonic stem cell line (H9). Tissue Eng Part C Methods (2014) 0.75
TLR4 Deficiency Impairs Oligodendrocyte Formation in the Injured Spinal Cord. J Neurosci (2016) 0.75
Intraspinal TLR4 activation promotes iron storage but does not protect neurons or oligodendrocytes from progressive iron-mediated damage. Exp Neurol (2017) 0.75
Metabolic pathways as possible therapeutic targets for progressive multiple sclerosis. Neural Regen Res (2017) 0.75
Iron and iron-handling proteins in the brain after intracerebral hemorrhage. Stroke (2003) 2.71
Co-localization of NG2 proteoglycan and PDGF alpha-receptor on O2A progenitor cells in the developing rat brain. J Neurosci Res (1996) 2.67
Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. J Neural Transm (1988) 2.10
The life, death, and replacement of oligodendrocytes in the adult CNS. J Neurochem (2008) 2.04
Binding and uptake of H-ferritin are mediated by human transferrin receptor-1. Proc Natl Acad Sci U S A (2010) 1.99
Oligodendrocytes and myelination: the role of iron. Glia (2009) 1.90
A p53-independent pathway for activation of WAF1/CIP1 expression following oxidative stress. J Biol Chem (1995) 1.82
Brain-derived neurotrophic factor in astrocytes, oligodendrocytes, and microglia/macrophages after spinal cord injury. Neurobiol Dis (2000) 1.59
Brain iron pathways and their relevance to Parkinson's disease. J Neurochem (2001) 1.55
Identification of post-mitotic oligodendrocytes incapable of remyelination within the demyelinated adult spinal cord. J Neuropathol Exp Neurol (1997) 1.53
Microglia-derived interleukin-6 and leukaemia inhibitory factor promote astrocytic differentiation of neural stem/progenitor cells. Eur J Neurosci (2007) 1.51
Iron deposits in multiple sclerosis and Alzheimer's disease brains. Brain Res (1997) 1.46
Transport of iron in the blood-brain-cerebrospinal fluid system. J Neurochem (1997) 1.45
Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington's disease. Glia (2007) 1.40
Low glutathione and high iron govern the susceptibility of oligodendroglial precursors to oxidative stress. J Neurochem (1996) 1.32
The relationship between intracellular free iron and cell injury in cultured neurons, astrocytes, and oligodendrocytes. J Neurosci (2002) 1.32
Prominent oligodendrocyte genesis along the border of spinal contusion lesions. Glia (2007) 1.29
Ferritin: a novel mechanism for delivery of iron to the brain and other organs. Am J Physiol Cell Physiol (2007) 1.29
Characterization and modeling of monocyte-derived macrophages after spinal cord injury. J Neurochem (2007) 1.28
Brain iron and ferritin in Parkinson's and Alzheimer's diseases. J Neural Transm Park Dis Dement Sect (1990) 1.27
NG2 colocalizes with axons and is expressed by a mixed cell population in spinal cord lesions. J Neuropathol Exp Neurol (2006) 1.19
Central nervous system-initiated inflammation and neurotrophism in trauma: IL-1 beta is required for the production of ciliary neurotrophic factor. J Immunol (2000) 1.17
Oligodendrocyte generation is differentially influenced by toll-like receptor (TLR) 2 and TLR4-mediated intraspinal macrophage activation. J Neuropathol Exp Neurol (2007) 1.15
Secretion of ferritin by rat hepatoma cells and its regulation by inflammatory cytokines and iron. Blood (1997) 1.14
Mature oligodendrocyte apoptosis precedes IGF-1 production and oligodendrocyte progenitor accumulation and differentiation during demyelination/remyelination. J Neurosci Res (2000) 1.14
The chemokine growth-regulated oncogene-alpha promotes spinal cord oligodendrocyte precursor proliferation. J Neurosci (1998) 1.13
Interleukin-1 regulates proliferation and differentiation of oligodendrocyte progenitor cells. Mol Cell Neurosci (2002) 1.12
Cellular distribution of ferritin subunits in postnatal rat brain. J Comp Neurol (1998) 1.11
Distinctive patterns of PDGF-A, FGF-2, IGF-I, and TGF-beta1 gene expression during remyelination of experimentally-induced spinal cord demyelination. Mol Cell Neurosci (1999) 1.10
Macrophages function as a ferritin iron source for cultured human erythroid precursors. J Cell Biochem (2008) 1.10
Cellular iron status influences the functional relationship between microglia and oligodendrocytes. Glia (2006) 1.09
Tim-2 is the receptor for H-ferritin on oligodendrocytes. J Neurochem (2008) 1.06
Isoforms of ferritin have a specific cellular distribution in the brain. J Neurosci Res (1994) 0.99
Ferritin, transferrin, and iron in selected regions of the adult and aged rat brain. J Comp Neurol (1993) 0.99
Nuclear ferritin: A new role for ferritin in cell biology. Biochim Biophys Acta (2010) 0.96
A histochemical study of iron-positive cells in the developing rat brain. J Comp Neurol (1995) 0.95
Oligodendrocyte progenitor cells internalize ferritin via clathrin-dependent receptor mediated endocytosis. J Neurosci Res (2000) 0.95
Iron deprivation inhibits cyclin-dependent kinase activity and decreases cyclin D/CDK4 protein levels in asynchronous MDA-MB-453 human breast cancer cells. Exp Cell Res (1996) 0.94
Iron chelators inhibit the growth and induce the apoptosis of Kaposi's sarcoma cells and of their putative endothelial precursors. J Invest Dermatol (2000) 0.92
Iron is essential for oligodendrocyte genesis following intraspinal macrophage activation. Exp Neurol (2009) 0.91
Synergism of nitric oxide and iron in killing the transformed murine oligodendrocyte cell line N20.1. J Neurochem (1999) 0.88
Abnormal iron accumulation is involved in the pathogenesis of the demyelinating dmy rat but not in the hypomyelinating mv rat. Brain Res (2010) 0.88
Distribution of transferrin and ferritin binding in normal and multiple sclerotic human brains. J Neurol Sci (1999) 0.88
Ceruloplasmin protects injured spinal cord from iron-mediated oxidative damage. J Neurosci (2008) 0.87
Expression of multiple genes regulating cell cycle and apoptosis in differentiating hematopoietic cells is dependent on iron. Exp Hematol (2001) 0.85
Regulation of p27(Kip1) by intracellular iron levels. Biometals (2004) 0.84
Iron modulates the differentiation of a distinct population of glial precursor cells into oligodendrocytes. Dev Biol (2001) 0.83
Modulation of ras p21 oncoprotein levels and DNA strand breakage in human cells with chemotherapeutic agents and/or deferoxamine. Teratog Carcinog Mutagen (1998) 0.78
Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci (2009) 6.93
Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J Neurotrauma (2006) 5.32
FoxM1 promotes β-catenin nuclear localization and controls Wnt target-gene expression and glioma tumorigenesis. Cancer Cell (2011) 3.58
Redundant pathways for negative feedback regulation of bile acid production. Dev Cell (2002) 3.51
TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity (2002) 3.46
Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol (2007) 3.06
Modulation of acetaminophen-induced hepatotoxicity by the xenobiotic receptor CAR. Science (2002) 2.66
Rapid diversification of cell signaling phenotypes by modular domain recombination. Science (2010) 2.49
Replication and reproducibility in spinal cord injury research. Exp Neurol (2011) 2.31
Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease. J Immunol (2003) 2.21
Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma. Genome Res (2013) 2.12
Wallerian degeneration: gaining perspective on inflammatory events after peripheral nerve injury. J Neuroinflammation (2011) 2.02
Rats and mice exhibit distinct inflammatory reactions after spinal cord injury. J Comp Neurol (2003) 1.94
Toll-like receptor (TLR)-2 and TLR-4 regulate inflammation, gliosis, and myelin sparing after spinal cord injury. J Neurochem (2007) 1.92
TL1A synergizes with IL-12 and IL-18 to enhance IFN-gamma production in human T cells and NK cells. J Immunol (2004) 1.85
Comparative analysis of lesion development and intraspinal inflammation in four strains of mice following spinal contusion injury. J Comp Neurol (2006) 1.84
Macrophages promote axon regeneration with concurrent neurotoxicity. J Neurosci (2009) 1.80
Regulation of PPARgamma coactivator 1alpha (PGC-1alpha) signaling by an estrogen-related receptor alpha (ERRalpha) ligand. Proc Natl Acad Sci U S A (2004) 1.60
Deficient CX3CR1 signaling promotes recovery after mouse spinal cord injury by limiting the recruitment and activation of Ly6Clo/iNOS+ macrophages. J Neurosci (2011) 1.59
Biosynthesis, purification, and substrate specificity of severe acute respiratory syndrome coronavirus 3C-like proteinase. J Biol Chem (2003) 1.54
Impaired antibody synthesis after spinal cord injury is level dependent and is due to sympathetic nervous system dysregulation. Exp Neurol (2007) 1.52
Potential role for TL1A, the new TNF-family member and potent costimulator of IFN-gamma, in mucosal inflammation. Clin Immunol (2004) 1.52
A reassessment of a classic neuroprotective combination therapy for spinal cord injured rats: LPS/pregnenolone/indomethacin. Exp Neurol (2011) 1.49
An efficient and reproducible method for quantifying macrophages in different experimental models of central nervous system pathology. J Neurosci Methods (2009) 1.48
Bone marrow transplants provide tissue protection and directional guidance for axons after contusive spinal cord injury in rats. Exp Neurol (2004) 1.47
Remote activation of microglia and pro-inflammatory cytokines predict the onset and severity of below-level neuropathic pain after spinal cord injury in rats. Exp Neurol (2008) 1.46
Low expression of LOC285194 is associated with poor prognosis in colorectal cancer. J Transl Med (2013) 1.45
Soluble TNF-like cytokine (TL1A) production by immune complexes stimulated monocytes in rheumatoid arthritis. J Immunol (2007) 1.44
Remission of rheumatoid arthritis and potential determinants: a national multi-center cross-sectional survey. Clin Rheumatol (2014) 1.41
TL1A-induced NF-kappaB activation and c-IAP2 production prevent DR3-mediated apoptosis in TF-1 cells. J Biol Chem (2003) 1.40
B cells produce pathogenic antibodies and impair recovery after spinal cord injury in mice. J Clin Invest (2009) 1.37
Meclizine is an agonist ligand for mouse constitutive androstane receptor (CAR) and an inverse agonist for human CAR. Mol Endocrinol (2004) 1.36
Neuroinflammation in spinal cord injury: therapeutic targets for neuroprotection and regeneration. Prog Brain Res (2009) 1.35
Inflammation and axon regeneration. Curr Opin Neurol (2011) 1.33
Pathological CNS autoimmune disease triggered by traumatic spinal cord injury: implications for autoimmune vaccine therapy. J Neurosci (2002) 1.33
The M-Ras-RA-GEF-2-Rap1 pathway mediates tumor necrosis factor-alpha dependent regulation of integrin activation in splenocytes. Mol Biol Cell (2007) 1.30
Prominent oligodendrocyte genesis along the border of spinal contusion lesions. Glia (2007) 1.29
Characterization and modeling of monocyte-derived macrophages after spinal cord injury. J Neurochem (2007) 1.28
Spinal cord injury triggers systemic autoimmunity: evidence for chronic B lymphocyte activation and lupus-like autoantibody synthesis. J Neurochem (2006) 1.25
Fractalkine receptor (CX3CR1) deficiency sensitizes mice to the behavioral changes induced by lipopolysaccharide. J Neuroinflammation (2010) 1.24
Inflammatory myofibroblastic tumor successfully treated with chemotherapy and nonsteroidals: a case report. World J Gastroenterol (2012) 1.21
Regional heterogeneity in astrocyte responses following contusive spinal cord injury in mice. J Comp Neurol (2010) 1.20
NG2 colocalizes with axons and is expressed by a mixed cell population in spinal cord lesions. J Neuropathol Exp Neurol (2006) 1.19
Stress exacerbates neuropathic pain via glucocorticoid and NMDA receptor activation. Brain Behav Immun (2009) 1.18
Progranulin expression is upregulated after spinal contusion in mice. Acta Neuropathol (2009) 1.17
The PPAR gamma agonist Pioglitazone improves anatomical and locomotor recovery after rodent spinal cord injury. Exp Neurol (2007) 1.16
Molecular control of physiological and pathological T-cell recruitment after mouse spinal cord injury. J Neurosci (2005) 1.16
Oligodendrocyte generation is differentially influenced by toll-like receptor (TLR) 2 and TLR4-mediated intraspinal macrophage activation. J Neuropathol Exp Neurol (2007) 1.15
Synthesis, crystal structure, vibration spectral, and DFT studies of 4-aminoantipyrine and its derivatives. Molecules (2013) 1.14
FoxM1B regulates NEDD4-1 expression, leading to cellular transformation and full malignant phenotype in immortalized human astrocytes. Cancer Res (2010) 1.14
A grading system to evaluate objectively the strength of pre-clinical data of acute neuroprotective therapies for clinical translation in spinal cord injury. J Neurotrauma (2010) 1.13
Stress hormones collaborate to induce lymphocyte apoptosis after high level spinal cord injury. J Neurochem (2009) 1.11
KLF4-mediated negative regulation of IFITM3 expression plays a critical role in colon cancer pathogenesis. Clin Cancer Res (2011) 1.11
Oligodendrocyte fate after spinal cord injury. Neurotherapeutics (2011) 1.09
3C-like proteinase from SARS coronavirus catalyzes substrate hydrolysis by a general base mechanism. Biochemistry (2004) 1.08
Enhanced axonal growth into a spinal cord contusion injury site in a strain of mouse (129X1/SvJ) with a diminished inflammatory response. J Comp Neurol (2004) 1.08
TPX2 is a novel prognostic marker for the growth and metastasis of colon cancer. J Transl Med (2013) 1.07
Autonomic dysreflexia causes chronic immune suppression after spinal cord injury. J Neurosci (2013) 1.07
Passive or active immunization with myelin basic protein impairs neurological function and exacerbates neuropathology after spinal cord injury in rats. J Neurosci (2004) 1.07
MICAL flavoprotein monooxygenases: expression during neural development and following spinal cord injuries in the rat. Mol Cell Neurosci (2005) 1.07
B cells and autoantibodies: complex roles in CNS injury. Trends Immunol (2010) 1.05
Semi-automated Sholl analysis for quantifying changes in growth and differentiation of neurons and glia. J Neurosci Methods (2010) 1.05
Minimum information about a spinal cord injury experiment: a proposed reporting standard for spinal cord injury experiments. J Neurotrauma (2014) 1.05
The critical role of dysregulated FOXM1-PLAUR signaling in human colon cancer progression and metastasis. Clin Cancer Res (2012) 1.05
Specific inhibition of Notch1 signaling enhances the antitumor efficacy of chemotherapy in triple negative breast cancer through reduction of cancer stem cells. Cancer Lett (2012) 1.04
2,3-Dimethyl-6-nitro-2H-indazole. Acta Crystallogr Sect E Struct Rep Online (2009) 1.04
Isatin compounds as noncovalent SARS coronavirus 3C-like protease inhibitors. J Med Chem (2006) 1.04
Experimental Effects and Individual Differences in Linear Mixed Models: Estimating the Relationship between Spatial, Object, and Attraction Effects in Visual Attention. Front Psychol (2011) 1.03
Chronically increased ciliary neurotrophic factor and fibroblast growth factor-2 expression after spinal contusion in rats. J Comp Neurol (2008) 1.03
Quantification of 8-iso-prostaglandin-F(2alpha) and 2,3-dinor-8-iso-prostaglandin-F(2alpha) in human urine using liquid chromatography-tandem mass spectrometry. Free Radic Biol Med (2003) 1.03
Silencing Nogo-A promotes functional recovery in demyelinating disease. Ann Neurol (2010) 1.02
The substrate specificity of SARS coronavirus 3C-like proteinase. Biochem Biophys Res Commun (2005) 1.01
A mouse model of ischemic spinal cord injury with delayed paralysis caused by aortic cross-clamping. Anesthesiology (2010) 1.00
Macrophage migration inhibitory factor potentiates autoimmune-mediated neuroinflammation. J Immunol (2013) 1.00
Enhanced thermoelectric performance in barium and indium double-filled skutterudite bulk materials via orbital hybridization induced by indium filler. J Am Chem Soc (2009) 0.99
Evaluation of ALK rearrangement in Chinese non-small cell lung cancer using FISH, immunohistochemistry, and real-time quantitative RT- PCR on paraffin-embedded tissues. PLoS One (2013) 0.99
Macrophage depletion alters the blood-nerve barrier without affecting Schwann cell function after neural injury. J Neurosci Res (2007) 0.98
Central nervous system and non-central nervous system antigen vaccines exacerbate neuropathology caused by nerve injury. Eur J Neurosci (2007) 0.98
Serotype and genotype diversity of infectious bronchitis viruses isolated during 1985-2008 in Guangxi, China. Arch Virol (2011) 0.97
N-(4-Chloro-2-nitro-phen-yl)-5-methyl-isoxazole-4-carboxamide. Acta Crystallogr Sect E Struct Rep Online (2011) 0.97
Anxiety after cardiac arrest/cardiopulmonary resuscitation: exacerbated by stress and prevented by minocycline. Stroke (2009) 0.97
Mucopolysaccharidosis IIIB, a lysosomal storage disease, triggers a pathogenic CNS autoimmune response. J Neuroinflammation (2010) 0.97
Frequent copy number variations of PI3K/AKT pathway and aberrant protein expressions of PI3K subunits are associated with inferior survival in diffuse large B cell lymphoma. J Transl Med (2014) 0.96
Quantitative proteomics study of breast cancer cell lines isolated from a single patient: discovery of TIMM17A as a marker for breast cancer. Proteomics (2010) 0.96
Only one protomer is active in the dimer of SARS 3C-like proteinase. J Biol Chem (2006) 0.95
Achieving CNS axon regeneration by manipulating convergent neuro-immune signaling. Cell Tissue Res (2012) 0.95
Dorsal telencephalon-specific RA-GEF-1 knockout mice develop heterotopic cortical mass and commissural fiber defect. Eur J Neurosci (2009) 0.94
Chronic oligodendrogenesis and remyelination after spinal cord injury in mice and rats. J Neurosci (2015) 0.94
Transforming growth factor α transforms astrocytes to a growth-supportive phenotype after spinal cord injury. J Neurosci (2011) 0.93
Toll-like receptors in spinal cord injury. Curr Top Microbiol Immunol (2009) 0.93
Pharmacokinetics and in vitro and in vivo anti-tumor response of an interleukin-2-human serum albumin fusion protein in mice. Cancer Immunol Immunother (2004) 0.92
Chronic expression of PPAR-delta by oligodendrocyte lineage cells in the injured rat spinal cord. J Comp Neurol (2010) 0.92
Mice lacking L1 cell adhesion molecule have deficits in locomotion and exhibit enhanced corticospinal tract sprouting following mild contusion injury to the spinal cord. Eur J Neurosci (2006) 0.92